Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Mogamulizumab Biosimilar - Anti-CCR4, CD194 mAb - Research Grade |
---|---|
Source | CAS 1159266-37-1 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Mogamulizumab,AMG-761,KW-0761,CCR4, CD194,anti-CCR4, CD194 |
Reference | PX-TA1258 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Mogamulizumab targets CC chemokine receptor 4 (CCR4) and is used for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS) which are subtypes of cutaneous T-cell lymphoma.
Related products
Reviews
Il n’y a pas encore d’avis.